do you have to keep taking semaglutide forever Long-Term Use: Duration & Sustainability Maximizing Semaglutide: Understanding the Doses

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are peptide-derived analogs that were initially investigated to treat type 2 diabetes

Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults In obese individuals without diabetes, tirzepatide was associated with a lower risk of cardiovascular events, especially incident HF, compared with semaglutide,

Labs were unremarkable upon admission

TRANSCEND-T2D-1: Retatrutide in adults with obesity and type 2 diabetes

Today, we announced new data from the latest Phase 3 study of retatrutide, an investigational triple hormone receptor agonist being studied for adults living with obesity or overweight with at least one weight-related comorbidity